Literature DB >> 7620163

Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.

A C Lankester1, G M van Schijndel, C E van der Schoot, M H van Oers, C J van Noesel, R A van Lier.   

Abstract

B chronic lymphocytic leukemia (B-CLL) are clonal populations of mIgM+ or mIgM+/mIgD+ CD5+ B cells that appear to be arrested in the follicular mantle-zone B-cell stage. Functional analyses have shown two groups of B-CLL that can be distinguished based on their capacity to proliferate in response to B-cell antigen receptor complex (BCR) cross-linking. To investigate the molecular basis for this phenomenon, we have analyzed both architecture and functional properties of BCR complexes on these two groups of B-CLL. Both groups were found to express structurally similar BCR. However, protein tyrosine kinase (PTK) activity associated with and specific for BCR constituents was strongly diminished in nonresponsive B-CLL. Moreover, the PTK-dependent assembly of Shc/Grb2 complexes, which may couple the BCR to p21ras, was absent in these B-CLL. Finally, of all PTKs tested, the expression of PTK syk was found to be considerably lower in nonresponsive B-CLL. Thus, absence of mitogenic responses upon BCR cross-linking in particular B-CLL was found to be strictly correlated with diminished induction of BCR-associated PTK activity and lower levels of PTK syk. Because nonresponsive B-CLL closely resembles tolerant autoreactive B cells both functionally and biochemically, distinction between B-CLL with respect to functional properties in vitro may be determined by differences in antigen encounter in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620163

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

Authors:  Lisa Pleyer; Alexander Egle; Tanja Nicole Hartmann; Richard Greil
Journal:  Nat Rev Clin Oncol       Date:  2009-06-02       Impact factor: 66.675

2.  Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

Authors:  Roberto Negro; Stefania Gobessi; Pablo G Longo; Yantao He; Zhong-Yin Zhang; Luca Laurenti; Dimitar G Efremov
Journal:  Blood       Date:  2012-05-08       Impact factor: 22.113

Review 3.  Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.

Authors:  Aaron E Foster; Malcolm K Brenner; Gianpietro Dotti
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 4.  Growth and survival of B-chronic lymphocytic leukaemia cells.

Authors:  O Söderberg
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

5.  Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.

Authors:  N Watanabe; T Iwamura; T Shinoda; T Fujita
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.

Authors:  M S Gordon; R M Kato; F Lansigan; A A Thompson; R Wall; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.

Authors:  Kiyotaka Kawauchi; Toshie Ogasawara; Masako Yasuyama
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

8.  Cancer risk after ABO-incompatible living-donor kidney transplantation.

Authors:  Erin C Hall; Eric A Engels; Robert A Montgomery; Dorry L Segev
Journal:  Transplantation       Date:  2013-09-15       Impact factor: 5.385

9.  Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL.

Authors:  Dimitar G Efremov; Adrian Wiestner; Luca Laurenti
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-09       Impact factor: 2.576

10.  Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.

Authors:  Carmela Gurrieri; Peter McGuire; Hong Zan; Xiao-Jie Yan; Andrea Cerutti; Emilia Albesiano; Steven L Allen; Vincent Vinciguerra; Kanti R Rai; Manlio Ferrarini; Paolo Casali; Nicholas Chiorazzi
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.